Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells

Biochemistry and Biophysics Reports

Volumn 5, Issue , 2016, Pages 8-15

  Tominaga, Shin ichi ^a   Ohta, Satoshi ^a   Tago, Kenji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Fibroblast; ST2 gene

Indexed keywords

EID: 84949034952     PISSN: None     EISSN: 24055808     Source Type: Journal    
DOI: 10.1016/j.bbrep.2015.11.020     Document Type: Article

References (27)

1. 0 state. FEBS Lett. 1988, 238:315-319.
2. Tominaga S. A putative protein of a growth-specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 1989, 258:301-304.
3. Yanagisawa K., Takagi T., Tsukamoto T., Tetsuka T., Tominaga S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type I. FEBS Lett. 1993, 318:83-87.
4. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
5. Hayakawa H., Hayakawa M., Kume A., Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 2007, 282:26369-26380.
6. Kuroiwa K., Li H., Tago K., Iwahana H., Yanagisawa K., Komatsu N., Oshikawa K., Sugiyama Y., Arai T., Tominaga S. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma 2000, 19:151-159.
7. Oshikawa K., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Ohno S., Tominaga S., Sugiyama Y. Elevated soluble ST2 protein levels in sera of asthma patients with an acute exacerbation. Am. J. Respir. Crit. Care Med. 2001, 164:277-281.
8. Kuroiwa K., Arai T., Okazaki H., Minota S., Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 2001, 284:1104-1108.
9. Oshikawa K., Kuroiwa K., Tokunaga T., Kato T., Hagihara S., Tominaga S., Sugiyama Y. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respir. Med. 2001, 95:532-533.
10. Tajima S., Oshikawa K., Tominaga S., Sugiyama Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 2003, 124:1206-1214.
11. Oshikawa K., Kuroiwa K., Yanagisawa K., Ohno S., Tominaga S., Sugiyama Y. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 2002, 165:1005-1009.
12. Kanda M., Ohto-Ozaki H., Kuroiwa K., Tominaga S., Watanabe E., Iwahana H. Elevation of ST2 protein levels in cerebrospinal fluid following subarachnoid hemorrhage. Acta Neurol. Scand. 2006, 113:327-333.
13. Weinberg E.O., Shimpo M., De Keulenaer G.W., MacGillivray C., Tominaga S., Solomon S.D., Rouleau J.L., Lee R.T. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002, 106:2961-2966.
14. Weinberg E.O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J.L., Lee R.T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003, 107:721-726.
15. Haga Y., Yanagisawa K., Ohto-Ozaki H., Tominaga S., Masuzawa T., Iwahana H. The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G. Eur. J. Biochem. 2003, 270:163-170.
16. Nagata A., Takezako N., Tamemoto H., Ohto-Ozaki H., Ohta S., Tominaga S., Yanagisawa K. Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells. Cell. Mol. Immunol. 2012, 9:399-409.
17. Tominaga S., Tago K., Tsuda H., Komine M. Dual function of IL-33 on proliferation of NIH-3T3 cells. Cytokine 2015, 72:105-108.
18. 1 phase in rodent fibroblasts. Gene Dev. 1993, 7:1559-1571.
19. Takezako N., Hayakawa M., Hayakawa H., Aoki S., Yanagisawa K., Endo H., Tominaga S. ST2 suppresses IL-6 production via the inhibition of IκB degradation induced by the LPS signal in THP-1 cells. Biochem. Biophys. Res. Commun. 2006, 341:425-432.
20. Tominaga S., Hayakawa M., Tsuda H., Ohta S., Yanagisawa K. Presence of a novel exon 2E encoding a putative transmembrane protein in human IL-33 gene. Biochem. Biophys. Res. Commun. 2013, 430:969-974.
21. Tominaga S., Jenkins N.A., Gilbert D.J., Copeland N.G., Tetsuka T. Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim. Biophys. Acta 1991, 1090:1-8.
22. Stylianou E., O'Neill L.A.J., Rawlinson L., Edbrooke M.R., Woo P., Saklatvala J. Interleukin 1 induces NF-κB through its type I but not its type II receptor in lymphocytes. J. Biol. Chem. 1992, 267:15836-15841.
23. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., Shanebeck K., Grabstein K.H., Dower S.K. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 1993, 90:6155-6159.
24. Townsend M.J., Fallon P.G., Matthews D.J., Jolin H.E., McKenzie A.N.J. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 2000, 191:1069-1075.
25. Gillibert-Duplantier J., Duthey B., Sisirak V., Salaün D., Gargi T., Tredan O., Finetti P., Bertucci F., Birnbaum D., Bendriss-Vermare N., Badache A. Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene 2012, 31:3516-3524.
26. Levescot A., Flamant S., Basbous S., Jacomet F., Feraud O., Bourgeois E.A., Bonnet M.-L., Giraud C., Roy L., Barra A., Chomel J.-C., Turhan A., Guilhot F., Girard J.-P., Gombert J.-M., Herbelin A. BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34(+) progenitors from chronic myeloid leukemia patients. Cancer Res. 2014, 74:2669-2676.
27. Kim J.Y., Lim S.-C., Kim G., Yun H.J., Ahn S.-G., Choi H.S. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity. Oncogene 2015, 34:4928-4938.